1.06360

溴化钠

EMPROVE^® ESSENTIAL, Ph. Eur., BP, JP, USP

• 同義詞: Sodium bromide, Bromo sodium
• 經驗公式（希爾表示法）: BrNa
• CAS號碼: 7647-15-6
• 分子量：: 102.89
• MDL號碼: MFCD00003475
• 分類程式碼代碼: 12352302
• 酶委員會索引編號: 231-599-9

屬性

• agency: BP; JP; Ph. Eur.; USP
• 品質等級: 500
• 蒸汽壓力: 1.3 hPa ( 806 °C)
• 產品線: EMPROVE^® ESSENTIAL
• 形狀: solid
• 技術: API processing | salt formation: suitable
• pH值: 5.74 (22.5 °C, 430 g/L in H₂O)
• 溶解度: 946 g/L
• 密度: 3.2 g/cm³ at 25 °C
• 應用: liquid formulation; pharmaceutical; solid formulation
• 儲存溫度: 15-25°C
• InChI: 1S/BrH.Na/h1H;/q;+1/p-1
• InChI 密鑰: JHJLBTNAGRQEKS-UHFFFAOYSA-M

描述

一般說明

Finding the right excipient that matches your needs as well as regulatory demands can be a complicated challenge in formulation. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our EMPROVE^® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC^® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

Sodium bromide is a mineral salt with diverse pharmaceutical applications, especially in veterinary medicine.

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

安全資訊

• 象形圖: GHS08,GHS07
• 訊號詞: Warning
• 危險聲明: H336,H361fd,H373
• 防範說明: P202 - P260 - P271 - P280 - P304 + P340 + P312 - P308 + P313
• 危險分類: Repr. 2 - STOT RE 2 - STOT SE 3
• 標靶器官: Central nervous system
• 儲存類別代碼: 13 - Non Combustible Solids
• 水污染物質分類（WGK）: WGK 1
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable